Medicure Financials
MCUJF Stock | USD 0.70 0.00 0.00% |
Medicure |
Medicure Stock Summary
Medicure competes with Grey Cloak. Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market in Canada and the United States. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada. Medicure is traded on OTC Exchange in the United States.Instrument | USA Pink Sheet View All |
Exchange | PINK Exchange |
Business Address | 2-1250 Waverley Street, |
Sector | Biotechnology |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.medicure.com |
Phone | 204 487 7412 |
Currency | USD - US Dollar |
Medicure Key Financial Ratios
There are many critical financial ratios that Medicure's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Medicure reports annually and quarterly.Medicure Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Medicure's current stock value. Our valuation model uses many indicators to compare Medicure value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medicure competition to find correlations between indicators driving Medicure's intrinsic value. More Info.Medicure is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about 0.14 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Medicure is roughly 7.06 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Medicure's earnings, one of the primary drivers of an investment's value.Medicure Systematic Risk
Medicure's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Medicure volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Medicure correlated with the market. If Beta is less than 0 Medicure generally moves in the opposite direction as compared to the market. If Medicure Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Medicure is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Medicure is generally in the same direction as the market. If Beta > 1 Medicure moves generally in the same direction as, but more than the movement of the benchmark.
Medicure December 12, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Medicure help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Medicure. We use our internally-developed statistical techniques to arrive at the intrinsic value of Medicure based on widely used predictive technical indicators. In general, we focus on analyzing Medicure Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Medicure's daily price indicators and compare them against related drivers.
Information Ratio | (0.05) | |||
Maximum Drawdown | 30.38 | |||
Value At Risk | (7.35) | |||
Potential Upside | 2.94 |
Complementary Tools for Medicure Pink Sheet analysis
When running Medicure's price analysis, check to measure Medicure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicure is operating at the current time. Most of Medicure's value examination focuses on studying past and present price action to predict the probability of Medicure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicure's price. Additionally, you may evaluate how the addition of Medicure to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Stocks Directory Find actively traded stocks across global markets | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |